How Diverse--CD4 Effector T Cells and their Functions by Wan, Y. Y. & Flavell, R. A.
Review
How Diverse—CD4 Effector T Cells and their
Functions
Yisong Y. Wan1,* and Richard A. Flavell2,3,*
1 Department of Microbiology and Immunology, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, School of Medicine,
North Carolina, NC 27599, USA
2 Department of Immunobiology, Yale University School of Medicine, 300 Cedar Street, New Haven, CT 06520-8011, USA
3 Howard Hughes Medical Institute, New Haven, CT 06520, USA
* Correspondence to: Yisong Y. Wan, Tel: þ1 919 966 9728; Fax: þ1 919 966 3015; E-mail: wany@email.unc.edu; Richard A. Flavell, Tel: þ1 203 737 2216;
Fax: þ1 203 785 7561; E-mail: Richard.Flavell@yale.edu
CD4 effector T cells, also called helper T (Th) cells, are the functional cells for executing immune functions. Balanced immune
responses can only be achieved by proper regulation of the differentiation and function of Th cells. Dysregulated Th cell function
often leads to inefficient clearance of pathogens and causes inflammatory diseases and autoimmunity. Since the establishment
of the Th1–Th2 dogma in the 1980s, different lineages of effector T cells have been identified that not only promote but also sup-
press immune responses. Through years of collective efforts, much information was gained on the function and regulation of differ-
ent subsets of Th cells. In this review, we attempt to sample the essence of what has been learnt in this field over the past two
decades. We will discuss the classification and immunological functions of effector T cells, the determinants for effector T cell differ-
entiation, as well as the relationship between different lineages of effector T cells.
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Introduction
Since birth, our immune system is constantly bombarded with
self-antigens, innocuous antigens and foreign pathogens, such
as airborne and food-borne viruses, bacteria and parasites. To
stay healthy, complex immune strategies have evolved in
mammals to maintain self-tolerance and to defend against
foreign pathogens. To accomplish such a daunting task, the
immune system has developed mechanisms to efficiently cope
with these insults in the living species. The two fundamental
arms of the immune response, innate and adaptive immunity,
jointly form a defensive front against pathogens. Innate immunity
evolved earlier and is mediated by cells such as macrophages and
dendritic cells (DC) and is specific only to a few classes of micro-
organisms. The later evolved adaptive immunity mediated by
T and B cells and enhances pathogen eradication in vertebrates
by adding antigen specificity and memory onto pre-existent
innate immunity. A defining property of adaptive immunity is the
antigen-driven differentiation of clonally restricted lymphocyte
precursors into effector cells with enhanced functional potential.
Effector T cells are the key players in steering the immune
responses to execute immune functions. While effector T cells
were initially identified to be immune promoting, recent studies
unraveled negative regulatory functions of effector T cells in mod-
ulating adaptive as well as innate immunity. The differentiation of
naı̈ve T cells into fully functional effector T cells is characterized
by the acquisition of new profiles of cytokine production and is
largely directed by cytokines produced by activated cells of the
innate, as well as adaptive, immune system. Key advances in
the understanding of effector T cells have been tied to cytokine
biology—cytokine production is vital for the classification and
function of effector T cells. Owing to their critical and diverse
functions in controlling immune responses, the functions and
regulation of effector T cells have been a subject of intense inves-
tigation since the Th1–Th2 paradigm was conceived and estab-
lished in 1986. In the ensuing years, vast knowledge has been
gained in identifying new classes of effector T cells and in under-
standing their functions and regulation.
Effector T cell lineages—old and
ever increasing new players
In immunology, different lineages of immune cells were convention-
ally distinguished by the morphology and expression of a cluster of
differentiation markers on the surface. In 1986, a seminal study by
Coffman and Mosmann revealed that cytokine profiles can be used
to categorize CD4 effector T cells, namely helper-T-cell-1 and -2
(Th1 and Th2), which possess different immunological functions
(Coffman and Carty, 1986; Mosmann et al., 1986).
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One important means of discovery is to approach old questions
with new techniques to explore new explanations. Immunology
has thrived through the processes of discovery and re-discovery.
The dawn of the Th1–Th2 dogma is a good example of such a prin-
ciple in practice. In the studies published in 1980s (Coffman and
Carty, 1986; Mosmann et al., 1986), Coffman and Mosmann and,
independently, Bottomly (Kim et al., 1985) proposed a model to
answer two older questions: are delayed-type hypersensitivity
and B cell help mediated by different types of helper T cells? And
how are allergic response and IgE production regulated? Based
on the studies conducted on mouse CD4 T cell clones using
state-of-art techniques for that time, they proposed that two
types of Th cells exist to promote reciprocal patterns of immunity
through the production of distinct cytokines: Th1 cells that make
IL-2 and IFN-g are important for classical delayed-type hypersensi-
tivity reactions, whereas Th2 cells that make IL-4 promote IgE pro-
duction and allergic reactions. In addition, they postulated that
each subset of Th cell promotes its own development and inhibits
the other via secreted cytokines; such that the induction of one
type of response suppresses the other. This hypothesis estab-
lished a new paradigm that Th cells are functionally heterogeneous
and cytokines are important for Th cell function and can be used to
distinguish different classes of Th cells. Such a notion fueled effec-
tor T cell research ever since and tremendous progress has been
made in identifying new types of effector T cells and in character-
izing their functions and regulation. Several types of effector T
cells have been documented with distinct biological functions.
Th1, Th2, Th17, Tfh and Th9 cells are involved in inflammatory
responses while regulatory T cell (Treg) including naturally occur-
ring Treg (nTreg), induced Treg (iTreg) and class 1 Treg (Tr1)
engage in immune suppression (Table 1).
Th1 cells
Th1 cells are defined based on the production of pro-inflammatory
cytokines IFN-g, TNF-a and TNF-b to stimulate innate and T cell
immune responses. Th1 cells also promote IgG2a or the equival-
ent IgG2c in other mouse strains production by B cells. The Th1
response tends to be dominated by cell-mediated forms of immu-
nity characterized by cellular cytolytic activity. Th1 cells are impor-
tant to protect the host from the obligate intracellular pathogens.
A classic example is its role during infection by Leishmania major,
a protozoal parasite. Such infection is lethal to genetically suscep-
tible but not to genetically resistant mouse strains (Sadick et al.,
1987). Protection of a resistant mouse strain, C57BL/6, correlated
with an appropriate IFN-g-mediated Th1 response, and suscepti-
bility of BALB/c mice correlated with an inappropriate
IL-4-mediated Th2 response (Heinzel et al., 1989). The Th1
response accounts for such protection because susceptible
BALB/c mice become resistant upon transfer of a Th1 cell line
specific to an immunodominant L. major antigen (Scott et al.,
1988). Th1 response and IFN-g production were also found to be
critical to protect hosts from infections by intracellular bacteria,
such as Mycobacterium avium (Kobayashi et al., 1997),
Salmonella typhimurium (Mastroeni et al., 1999) and Listeria
monocytogenes (Buchmeier and Schreiber, 1985), by fungi,
such as Cryptococcus neoformans (Zhang et al., 1997), and by
viruses, such as herpes simplex virus (HSV) (Fujioka et al.,
1999), influenza A virus (Sareneva et al., 1998) and vaccinia
virus (Tanaka-Kataoka et al., 1999). In addition to the beneficial
effects of clearing foreign pathogens, Th1 response also helps
tumor immune rejection. For example, Th1 CD4þ T cells were
shown to be important in maintaining the host as tumor free in
a transferred sarcoma model (Micallef et al., 1997).
On the one hand, the pro-inflammatory properties of Th1 cells
are suited for pathogen clearance and anti-tumor immunity; on
the other hand, they can cause tissue damage and elicit
unwanted inflammatory disease and self-reactivity. Th1 cells
and IFN-g contribute to inflammatory diseases such as inflamma-
tory bowel disease (IBD) (Davidson et al., 1996; Parronchi et al.,
1997) and graft-versus-host disease in recipients following bone
marrow transplantation (Hu et al., 1999), as well as autoimmune
disorders such as insulin-dependent diabetes mellitus (also
known as type-1 diabetes) (Wang et al., 1997; Pakala et al.,
1999) and rheumatoid arthritis (RA) (Leung et al., 2000).
Th2 cells
Th2 cells are defined as producers of IL-4, IL-5, IL-9, IL-10 and IL-13.
Th2 cells promote IgG1 and IgE class-switching and eosinophil
recruitment (Arthur and Mason, 1986; Coffman and Carty, 1986;
Mosmann et al., 1986; Paliard et al., 1988; Firestein et al., 1989).
Unlike the Th1 response, the Th2 response is often associated
with humoral responses during which high levels of pathogen-
Table 1 Category, differentiation and function of effector CD4 Th cells.




IFN-g TNF-a; TNF-b STAT4;
T-bet; Hlx
IL-4; IL-5; IL-10; IL-13 STAT6;
GATA3; c-maf; IRF4; Gfi-1
IL-9 IL-17; IL-21; IL-22 ROR-a
ROR-gt
IL-21 TGF-b IL-10 Foxp3
inducing cytokines IL-12; IL-18; IL-27; IFN-g IL-4 TGF-b/IL-4 IL-6/TGF-b IL-21/TGF-b
IL-23
IL-21 TGF-b IL-10; IL-2; TSLP











immune pathology involved IBD; GVHD; IDDM (T1D);
RA




Th1, Th2, Th17, Th9, Tfh and Treg effector CD4 T cells are defined based on the cytokines produced. Lineage-specific transcription factors critical for a particular Th cell
differentiation and function are activated following inducing cytokine stimulation. Fully functional Th cells contribute to the clearance of specific types of pathogens and
are involved in certain inflammatory and autoimmune diseases.
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specific immunoglobulin are generated to neutralize foreign organ-
isms. Thus, the Th2 response is important to resist extracellular
forms of pathogens, such as helminthes and nematodes
(Finkelman et al., 1991; Sher and Coffman, 1992). Th2 cells are
also important for mucosal immunity (mucus hyper-secretion and
increased contractility) in the lung. An over-exuberant Th2 response
leads to pathological changes in the host. Chronic inflammatory
airway diseases, such as atopic asthma and allergy characterized
by local infiltration with allergen-specific CD4 T cells, were attribu-
ted to Th2 cells (Wierenga et al., 1990; Kay et al., 1991; Parronchi
et al., 1991; Durham et al., 1992; Robinson et al., 1992; Yssel
et al., 1992; Ebner et al., 1993). Because the Th2 response is con-
sidered to combat pathogens of more recent origins compared
with the Th1 response, it is thought that Th2 immunity evolved
after Th1 immunity in vertebrates.
Th17 cells
Th17 cells are a newly identified class of effector T cells attracting
much attention recently. As indicated by the name, Th17 cells
produce IL-17A, E and F among the six members of IL-17 family,
IL-17A, B, C, D, E (or IL-25) and F (Fort et al., 2001; Kolls and
Linden, 2004; Langrish et al., 2005). It is now becoming clear
that Th17 cells also produce IL-21 and IL-22 (Liang et al., 2006;
Nurieva et al., 2007; Korn et al., 2007; Zheng et al., 2007). The
Th17 response seems to share commonality with both Th1 and
Th2 responses. Th17 cells have been suggested to contribute
to the resistance to Listeria, Salmonella, Toxoplasma,
Cryptococcus, Leishmania and Francisella (Lieberman et al.,
2004; Chackerian et al., 2006; Kleinschek et al., 2006). A few
infection models have shown a significant and specific role for
the Th17 response, including Klebsiella infection in the lung
(Happel et al., 2005), intravenous Candida albicans infection
(Huang et al., 2004), and infection of the natural rodent pathogen
Citrobacter rodentium in the gut (Mangan et al., 2006). In
addition, the preferential production of IL-17 by T cells during
infection with Bacteroides fragilis (Chung et al., 2003), Borrelia
burgdoferi, Mycobacterium tuberculosis (Infante-Duarte et al.,
2000) and fungal species (LeibundGut-Landmann et al., 2007)
suggests that Th17 responses are triggered by specific pathogens
and are required for their clearance. In addition to controlling
infection, Th17 cells play an important role in the induction and
propagation of autoimmunity. IL-17 expression has been associ-
ated with autoimmune diseases such as multiple sclerosis (MS),
RA, psoriasis, IBD, as well as allergic responses (Langrish et al.,
2005; Yen et al., 2006). In particular, Th17 cells are critical for
the development of MS/EAE (experimental autoimmune encepha-
lomyelitis) and RA (Bush et al., 2002; Nakae et al., 2003;
Hofstetter et al., 2005; Langrish et al., 2005; Komiyama et al.,
2006), whose development was originally attributed to Th1 cells
before the discovery of Th17 cells. While it is accepted that
Th17 is a T cell lineage distinct from Th1 and Th2, its evolution
in relation to Th1 and Th2 is under debate.
Treg cells
Naturally occurring regulatory T cells (nTreg) are a subset of CD4 T
cells that develop in the thymus and constitutively express high
levels of IL-2 receptor a chain (CD25), CTLA-4 and GITR. nTreg
comprises 5–10% of peripheral CD4 T cells. They produce
increased levels of IL-10 and membrane-bound forms of TGF-b
(Nakamura et al., 2001). Strictly speaking, nTreg may not
qualify as an effector T cell according to the traditional definition
in that they do not actively secrete large amounts of effector cyto-
kines in order to engage in immune regulation. However, unlike
naı̈ve T cells possessing little immune activity, nTreg produces
inhibitory effector cytokines and actively modulates immune
responses with potent activities. Thus, in a broader sense,
nTreg is a type of effector T cell. The induced regulatory T cell
(iTreg) is differentiated from naı̈ve T cells in the presence of
TGF-b following T cell receptor (TCR) stimulation. These cells
produce large amounts of IL-10 and TGF-b (Weiner, 2001;
Stassen et al., 2004). Unlike Th1, Th2 or Th17 cells, iTreg displays
immune-suppressive activity with minimal antigen specificity. Tr1
is another regulatory T cell subset producing IL-10 and TGF-b but
distinct from iTreg according to other molecular signatures, such
as Foxp3 expression (Vieira et al., 2004).
The most prominent function of Treg cells is to maintain self-
tolerance and immune homeostasis. nTreg cells were initially
identified to be critical for self-tolerance, because disruption of
their function invariably results in a systemic lymphoproliferative
autoimmune syndrome in both mice and humans (Sakaguchi
et al., 1995; Shevach, 2000, 2002; Sakaguchi, 2004). Disruption
of Treg function contributes to a plethora of autoimmune and
inflammatory pathologies. Treg are also suggested to be impor-
tant for tempering immune responses against infectious agents
and in re-establishing immune homeostasis following pathogen
clearance (Belkaid, 2008). Interestingly, a recent study suggests
that Treg can also facilitate immune response against HSV infec-
tion by recruiting natural killer (NK) cells, DC and T cells to the site
of infection (Lund et al., 2008).
Follicular helper T cells
Tfh (follicular helper T cells) are found enriched in the edge of the
B cell zones and follicular regions and germinal centers. Tfh cells
express high levels of CXCR5, the receptor for chemokine CXCL13
that is abundant in B cell zones (Ansel et al., 2000). Tfh-promoted
generation of high-affinity antibodies and memory B cells were
initially ascribed to Th1 and/or Th2 mechanism. However,
recent evidence suggests that Tfh is a unique effector T cell
subset expressing B cell-promoting cytokine IL-10 and IL-21
that are not typically associated with Th1 or Th2 cells
(Chtanova et al., 2004; Nurieva et al., 2008; Suto et al., 2008;
Vogelzang et al., 2008). With IL-21 expression, Tfh is nevertheless
distinct from Th17 cells (Nurieva et al., 2008), because Tfh can
differentiate independent of TGF-b and retinoid-related orphan
receptors that are essential for Th17 differentiation.
Th9 cells
Th9 cells are a new type of helper T cells independently reported
by Stockinger’s and Kuchroo’s groups (Dardalhon et al., 2008;
Veldhoen et al., 2008). These cells generate high levels of IL-9
and IL-10. Th9 cells share commonalities with Th2 cells and yet
are distinct by their IL-9 production. It appears that Th9 cells
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are involved in intestinal responses to helminthes (Khan et al.,
2003), which were traditionally thought to be mediated by the
Th2 response. Whether cells producing IL-9 are fully differentiated
effector cells and thus can be anointed with the appellation of Th9
remains to be validated. In addition, further studies are needed to





In a host that has not experienced foreign antigens, effector T
cells are rare. The differentiation of effector T cells requires
antigen-driven clonal expansion of naive T cell precursors. Th
cells may be generated through two mechanisms: 1) They arise
from distinct precursors that are predisposed to develop into
different lineages or 2) a common undifferentiated precursor
can be instructed to differentiate into various lineages. With
studies using TCR transgenic models, which provided uniform
naı̈ve T cell precursors with identical antigenic specificity, it is
recognized that the latter is the dominant mechanism for Th cell
differentiation. Many factors influence Th cell differentiation.
TCR stimulation, co-stimulation, kinase cascades, cytokine signal-
ing and transcriptional networks are all involved in Th lineage
decision, with cytokine signaling being recognized as the predo-
minant factor in driving Th differentiation. What signaling mech-
anisms, from the cell surface to the nucleus, instruct the




TCR and major histocompatibility complex II (MHCII) interaction
(signal I) is required for CD4 T cell activation. The nature of the anti-
genic stimulus influences Th polarization (Constant and Bottomly,
1997; Tao et al., 1997). Studies using altered peptide ligands
showed that the affinity between TCR and peptide-bound MHCII,
thus the strength of TCR stimulation, affects lineage commitment,
potentially by controlling the duration or magnitude of Ca2þ
fluxes (Sloan-Lancaster et al., 1997). The differential inclusion of
specific membrane-bound factors into lipid rafts, known as
SupraMolecular Activation Clusters (SMAC) (Cherukuri et al.,
2001; Galbiati et al., 2001), in Th1 and Th2 cells may account for
this phenomenon (Balamuth et al., 2001). The SMAC composition
of resting effector Th1 and effector Th2 cells are indistinguishable.
However, Th1 cells but not Th2 cells showed increased sensitivity
to low-affinity stimulation (Balamuth et al., 2001), while they both
responded efficiently to high-affinity antigens.
Besides TCR signal co-stimulation (signal II), mediated through
CD28-B7 and other surface molecules, is essential for efficient T
cell activation. Such molecules have also been suggested in influ-
encing Th1 and Th2 differentiation. Compared with Th1, the Th2
response was more pronouncedly affected in CD28- or
B7-deficient mice (Freeman et al., 1993; Green et al., 1994;
Schweitzer et al., 1997). Inducible T-cell co-stimulator (Dong
et al., 1999) and OX40 (Akiba et al., 2000) signaling were also
shown to be preferentially required for Th2 differentiation. The
interactions between LFA-1 and ICAM-1, -2 appear to inhibit Th2
response (Salomon and Bluestone, 1998; Smits et al., 2002).
Depending on the types of ligands the receptor binds, Notch sig-
naling that is known to be critical for T cell thymic development
is also important in directing T cell differentiation; ligand Delta
induces Th1, while ligand Jagged induces Th2 (Amsen et al., 2004).
The proximal event following T cell-APC synapse formation is
immediate activation of several signaling molecules: The Src
kinase phosphorylates and activates Tec tyrosine kinases,
which then activate PLC-g that is required for IP3 generation to
sustain intracellular calcium flux. Rlk (Txk in human) is a
member of Tec family shown to be sufficient and required for
IFN-g but not IL-4 production (Kashiwakura et al., 1999; Takeba
et al., 2002). In addition, RIBP, a Txk-binding protein is specifically
required for IFN-g production (Rajagopal et al., 1999). However,
another Tec family member Itk appears to be required for IL-4 pro-
duction and Th2 response upon infection with L. major, nematode
Nippostrongylus brasiliensis or Schistosoma mansoni eggs
(Fowell et al., 1999; Schaeffer et al., 2001). Therefore, Tec
kinases are important for Th1–Th2 divergence by integrating
antigen-stimulation signals. The roles of TCR stimulation,
co-stimulation and proximal signaling events in the differentiation
of recently characterized Th17, Th9 and Treg cells remain to be
addressed.
Cytokines
The cytokine milieu is arguably the most dominant determinant of
Th cell differentiation. To combat various types of pathogens,
innate cells as well as T cells generate different sets of cytokines
to skew T cell differentiation—different cytokine environments
instruct T cells to differentiate into different Th lineages
(Table 1 and Figure 1).
For Th1 differentiation
IFN-g. IFN-g is a signature cytokine for Th1 cells; it is also
suggested to be important for the differentiation of these cells.
The major sources for IFN-g are NK, CD8 and CD4 Th1 cells.
Naı̈ve CD4 T cells and B cells were also shown to produce
IFN-g. Whether macrophages and DC make IFN-g remains contro-
versial (Munder et al., 1998; Yoshimoto et al., 1998; Ohteki et al.,
1999; Fukao et al., 2000). Many lymphoid (including T cells) and
non-lymphoid cell types express heterodimeric IFN-g receptor-1
and -2, and thus can be stimulated by IFN-g through the Jak1/
Jak2-STAT1 signaling pathway (Bach et al., 1997; Leonard and
O’shea, 1998). Impairment of this pathway leads to compromised
immune responses against microbial pathogens and certain
viruses in mice (Cooper et al., 1993; Dalton et al., 1993; Huang
et al., 1993; Kamijo et al., 1993; Durbin et al., 1996; Meraz
et al., 1996) and humans (Jouanguy et al., 1996; Jouanguy
et al., 1999; Newport et al., 1996; Pierre-Audigier et al., 1997).
As a signature cytokine for Th1 cells, the exact role for IFN-g in
directing Th1 differentiation is, however, debatable. Early
studies demonstrated an involvement of IFN-g in Th1
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differentiation in vivo during L. major clearance (Scott, 1991).
Neutralization of IFN-g protein and deficiency in IFN-g gene led
to abrogated Th1 development (Belosevic et al., 1989; Wang
et al., 1994) in C3H and C56BL/6 mice. However, according to
one study, Th1 cells were generated normally in IFN-gR1
deficient mice on a 129/Sv/Ev background (Swihart et al.,
1995). In vitro, IFN-g promotes Th1 differentiation of CD4 T
cells from the C57BL/6 and B10.BR strains (Bradley et al.,
1996). Such an effect was dependent on IFN-gR2 (Swihart
et al., 1995). And yet, IFN-g alone was shown to be insufficient
for the induction of optimal Th1 differentiation of CD4 T cells
from BALB/c mice in vitro (Macatonia et al., 1993; Wenner
et al., 1996). These results strongly suggest that the discrepan-
cies observed in IFN-g effects on Th1 development can be
largely attributed to mouse strain differences.
IL-12. IL-12 is a soluble factor that potently induces Th1 differ-
entiation (Manetti et al., 1993; Seder et al., 1993; Hsieh et al.,
1993a, b; Manetti et al., 1994). IL-12 comprises two subunits,
p35 and p40. Note that p40 is shared by another cytokine,
IL-23, that is important for Th17 differentiation, which will be dis-
cussed in the later text. IL-12 is generated by innate cells follow-
ing activation and IFN-g stimulation (Kato et al., 1996; Koch et al.,
1996; Ma et al., 1996). IL-12 binds to its receptor to activate Jak2/
Tyk2-STAT1, 3, 4 signaling pathways (Gately et al., 1998).
CD4 T cells only upregulate IL-12R upon TCR stimulation (Presky
et al., 1996). Functional IL-12R is maintained on Th1 cells, but
diminishes on Th2 cells (Rogge et al., 1997; Szabo et al., 1997).
IL-12 signaling appears to be necessary for the expression of
IL-18Ra (Yoshimoto et al., 1998; Sareneva et al., 2000), a receptor
for IL-18, which is an IL-1 family cytokine that serves as a cofactor
for IL-12 in promoting IFN-g production in CD4 T cells and Th1
differentiation (Robinson et al., 1997). Because Th1 cells maintain
IL-12 and IL-18 receptor expression even in the resting state, IL-12
and IL-18 stimulation induces large amounts of IFN-g by
differentiated Th1 cells in the absence of TCR stimulation
(Micallef et al., 1996; Kohno et al., 1997). Mice deficient in
IL-12, IL-12R or STAT4 have profoundly diminished Th1 responses
in vitro and in vivo (Thierfelder et al., 1996; Magram et al., 1996a;
Kaplan et al., 1996b; Cooper et al., 1997; Wu et al., 1997; Wu et al.,
2000). Humans with defective IL-12R signaling display compro-
mised immune responses, especially to microbial infections (de
Jong et al., 1998; Altare et al., 1998a, b; Gollob et al., 2000). As
important as IL-12 signaling is for Th1 program, IL-12 is not the
sole factor that controls Th1 responses (Thierfelder et al., 1996;
Magram et al., 1996a; Kaplan et al., 1996b; Cooper et al., 1997;
Wu et al., 1997; Wu et al., 2000). IFN-g-producing T cells could
still be detected in mice deficient for IL-12 signaling (Magram
et al., 1996b; Kaplan et al., 1998; Schijns et al., 1998;
Brombacher et al., 1999; Oxenius et al., 1999; Mullen et al.,
2001; Jankovic et al., 2002). In addition, lymphocytic choriomenin-
gitis virus, vesicular stomatitis virus, mouse hepatitis virus,
Toxoplasma gondii and M. avium all elicited Th1 responses that
appeared to be largely independent of IL-12 (Schijns et al., 1998;
Oxenius et al., 1999; Jankovic et al., 2002). However, the long-term
resistance to T. gondii and L. major were found to be dependent on
IL-12 (Park et al., 2000; Stobie et al., 2000; Yap et al., 2000).
Collectively, these findings suggest that IL-12 may not be required
to initiate the Th1 program but rather be more important for sus-
taining optimal IFN-g production following T cell activation.
IL-27. IL-27 is a novel cytokine that shares several character-
istics with IL-12 and IL-18 (Pflanz et al., 2002). Like IL-12, IL-27
induces Th1 differentiation from mouse and human naı̈ve CD4 T
cells; like IL-18, IL-27 synergizes with IL-12 to potently induce
IFN-g production (Pflanz et al., 2002). IL-27 is composed of EBI3
(Epstein-Barr virus-induced gene 3), a p40 homolog, and a
novel subunit, p28. IL-27 binds to type I cytokine receptor
family named WSX-1 (Sprecher et al., 1998) or T cell cytokine
receptor (TCCR) (Chen et al., 2000) to activate STAT1 and
promote expression of IL-12Rb2 and IFN-g (Hibbert et al., 2003;
Takeda et al., 2003). IL-27R is highly expressed in T cells
(Sprecher et al., 1998) but downregulated following activation
(Chen et al., 2000). WSX-1- and TCCR-deficient mice exhibited
impaired Th1 responses (Chen et al., 2000; Yoshida et al.,
2001). Defective IFN-g production in T cells from
WSX-1-deficient mice was limited to the primary response but
not secondary responses (Yoshida et al., 2001). In addition,
both WSX-1- and TCCR-deficient mice demonstrated markedly
increased susceptibility to infection with the intracellular patho-
gens L. monocytogenes (Chen et al., 2000) and L. major
(Yoshida et al., 2001). Therefore, IL-27R may play an important
role in early Th1 differentiation processes prior to IL-12R
complex expression. The signal transduction pathway utilized
by IL-27 warrants further study, which may lead to the identifi-
cation of novel factors important for Th1 differentiation.
For Th2 and Th9 differentiation
IL-4 was initially identified and has remained as the most domi-
nant, if not the only, cytokine known to have the greatest influ-
ence in driving Th2 differentiation (Le Gros et al., 1990; Swain
et al., 1990). IL-4 binding to its receptor IL-4Ra triggers STAT6
Figure 1 The balancing act of cytokines in Th differentiation and con-
version. Largely through the effects of cytokines, different types of Th
cells counterbalance each other to achieve immune homeostasis.
Under certain circumstances, one type of Th cell converts into
another (shown by dotted green lines) to facilitate desired immune
responses.
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activation and Th2 differentiation. The ability of primed CD4þ T
cells to produce IL-4 upon re-stimulation was directly correlated
with the concentration of exogenous IL-4 added to the primary
culture. In addition, neutralizing antibody-mediated IL-4
depletion abrogates the generation of Th2 cells, suggesting that
the presence of some IL-4, even if endogenously derived, is
essential for Th2 differentiation. Moreover, with diminished Th2
cytokine production, IL-4 deficient mice are defective in
Th2-mediated pathogen clearance and develop less Th2-type
autoimmune diseases, underscoring the critical role for IL-4 in
programming Th2 differentiation (Kuhn et al., 1991; Grunewald
et al., 1998; Urban et al., 1998; Kurup et al., 1999). IL-4 in com-
bination with TGF-b has been shown to drive the differentiation
of a newly identified Th9 cell lineage, revealing the diverse
effect of this cytokine involving in multiple lineage determination
(Dardalhon et al., 2008; Veldhoen et al., 2008).
For Th17 differentiation
TGF-b and IL-6. TGF-b and IL-6 act cooperatively and non-
redundantly to promote Th17 commitment (Bettelli et al., 2006;
Mangan et al., 2006; Veldhoen et al., 2006a). When activated in
the presence of LPS-stimulated antigen presenting cells and
CD4þCD25þ nTreg, naı̈ve T cells expressed high levels of IL-17A
but diminished levels of Th1 or Th2 cytokines. TGF-b, a cytokine
that will be discussed in the later text, is required for IL-17 pro-
duction under such experimental settings (Veldhoen et al.,
2006a). Importantly, in addition to TGF-b, differentiation of
IL-17-producing effector cells required a soluble DC factor elicited
by TLR- and MyD88-dependent signaling, which proved to be IL-6.
Later study found that TGF-b together with IL-6, which alone
induces IL-22 (Zheng et al., 2007), promoted the generation of
Th7 cells and showed further that addition of IL-6 suppressed
the TGF-b-induced generation of Foxp3þ Treg while reciprocally
promoting the generation of Th17 cells (Bettelli et al., 2006;
Mangan et al., 2006). In vivo, mice deficient for TGF-b1 were
essentially devoid of Th17 cells (Mangan et al., 2006). Similarly,
blockage of TGF-b signaling through the over-expression of a
dominant negative form of TGF-b receptor in T cells blocked
EAE development and Th17 differentiation (Veldhoen et al.,
2006b). Autocrine TGF-b appears to be the predominant mechan-
ism for Th17 differentiation because mice with T cell-specific
deletion of TGF-b1 were protected from myelin oligodendrocyte
glycoprotein-induced EAE and failed to generate Th17 cells in
the central nervous system (CNS) following disease induction
(Li et al., 2007). In addition, mice transgenic for TGF-b under
the control of the IL-2 promoter had enhanced Th17 differen-
tiation and exacerbated EAE, whereas IL-6 deficiency inhibited
such phenomenon (Bettelli et al., 2006), suggesting a critical
role for IL-6 in Th17 differentiation in vivo. Considering the impor-
tance of the newly appreciated Th17 cells in pathogen clearance
and autoimmunity, further study is warranted to investigate the
mechanisms utilized by TGF-b and IL-6 in instructing Th17
differentiation.
IL-23 and IL-21. IL-23 and IL-21 are cytokines produced by
innate and T cells respectively and are shown to be important
for Th17 differentiation. The discovery of IL-23 solved a scientific
dilemma that bewildered researchers for many years: the
IL-12-dependent Th1 cells were thought to be essential for the
induction of autoimmunity, such as EAE and collagen-induced
arthritis (CIA), based on the studies performed using
p40-deficient mice or antibody to neutralize p40. However,
although p40 is essential for the development of CNS inflam-
mation during EAE, mice that are deficient in IFN-g signaling
(IFN-, IFNR-, and STAT1-deficient) developed more severe pathol-
ogy (Langrish et al., 2004). Similarly, during CIA, treatment with
p40-specific antibodies prevented disease, but the absence of
IFN-g signaling pathway resulted in increased arthritic disease
(Manoury-Schwartz et al., 1997; Vermeire et al., 1997; Chu
et al., 2003). Now we know that p40 not only binds to p35 to
form IL-12 but also binds to p19 to form IL-23 (Oppmann et al.,
2000) and IL-23 accounts for this disparity through regulating
Th17 differentiation. Indeed, IL-23-driven IL-17-producing cells
are shown to be highly potent at inducing CNS immune pathology
(Langrish et al., 2004), and IL-23-deficient mice are resistant to
the development of CIA (Murphy et al., 2003). Unlike TGF-b and
IL-6, which are critical for the induction of Th17 cells, IL-23 is cur-
rently thought to be critical for promoting the survival and pro-
liferation of differentiated Th17 cells.
IL-23 binds to the IL-23R complex composed of IL-12Rb1 chain
and a novel receptor chain (IL-23R) related to IL-12Rb2 and
gp130. Jak2/Tyk2-STAT1, 3, 4, and 5 are involved in its intracellu-
lar signal transduction (Parham et al., 2002). In contrast to IL-12,
IL-23 predominantly activates STAT3, but not STAT4.
IL-21 is an IL-2 family member that was recently found to be
highly produced by Th17 cells. IL-21 can substitute for IL-6 to
induce Th17 cells along with TGF-b (Korn et al., 2007; Nurieva
et al., 2007; Zhou et al., 2007). IL-21-activated signaling pathways
critical for Th17 differentiation and its biological function under
physiological and pathological conditions remain to be
established.
For Tfh differentiation
IL-21 has recently been found to be critical for Tfh differentiation.
IL-21 promotes CXCR5 expression in Tfh cells through IL-21R that
is highly expressed in these cells (Vogelzang et al., 2008). Mice
deficient in IL-21 or IL-21R have a severe defect in numbers of
Tfh cells (Nurieva et al., 2008; Vogelzang et al., 2008). Being
highly produced by Tfh cells, IL-21 thus appears to promote and
stabilize Tfh differentiation through an autocrine, feed-forward
mechanism. Whether there are other cytokines besides IL-21
that are able to promote and maintain Tfh cells warrants further
study in the future.
For Treg development and differentiation
IL-2. IL-2 is a cytokine produced mainly by activated T lympho-
cytes (Thornton and Shevach, 1998). The IL-2 receptor is composed
of three subunits: a (CD25), b, and common g (gc) chains. The gc
chain of IL-2R is shared by the receptors for IL-4, -7, -9, -15 and
-21. In T cells, binding of IL-2 leads to activation of the
JAK3-STAT5 pathway (Friedmann et al., 1996; Lin and Leonard,
1997). Early studies suggest that IL-2 is specifically required for
the development and maintenance of nTregs. In mice, antibody-
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mediated depletion of IL-2 or genetic disruption of IL-2 signaling
invariantly leads to autoimmune diseases associated with
reduced numbers of peripheral Foxp3-expressing nTregs (Schorle
et al., 1991; Sadlack et al., 1993; Suzuki et al., 1995; Snow
et al., 2003; Setoguchi et al., 2005). However, IL-2 signaling is
not absolutely required for the development of nTregs. A recent
study demonstrated that substantial amounts of Foxp3þ nTreg
cells, albeit reduced in number, were recovered from the thymus
and peripheral lymphoid organs when the IL-2 or CD25 gene was
lacking (Fontenot et al., 2005). IL-2 has also been shown to activate
and be required for optimal nTreg function (de la Rosa et al., 2004;
Thornton et al., 2004a, b), likely through facilitating their
proliferation and survival. It is therefore coming to a consensus
that IL-2 safeguards the ‘metabolic fitness’ of nTreg to maintain
their survival and homeostasis (Fontenot et al., 2005).
Thymic stromal lymphopoietin. Thymic stromal lymphopoietin
(TSLP) is an IL-7-like cytokine that binds to IL-7Ra. TSLP was
shown to induce the generation of thymic nTreg specifically via
DC in vitro (Watanabe et al., 2005). TSLP-expressing Hassall’s
corpuscles interact with and activate lysosomal membrane
glycoproteinþ DCs, which display upregulated CD80 and CD86
but not proinflammatory cytokines. More importantly, TSLP-
activated DC potently induced CD4þ thymic nTreg in a TCR- and
co-stimulation-dependent manner. This study demonstrates that
interactions among epithelial cells, DC, and T cells bridged by
cytokines are important for the generation of thymic nTreg
(Watanabe et al., 2005). It nevertheless remains to be addressed
whether such in vitro systems recapitulate what happens in vivo.
TGF-b. TGF-b is a family of pleiotropic cytokines consisting of
TGF-bs, bone morphogenetic proteins, activins, and growth
differentiation factors (Chang et al., 2002). TGF-b1 is the
isoform predominantly expressed in the immune system (Li
et al., 2006). TGF-b1 binds to a hetero-dimeric receptor that
initiates intracellular signaling through Smad and mitogen-
activated protein kinase (MAPK) (Massague, 1998). Early
studies revealed that TGF-b1 promotes the de novo generation
of iTreg accompanied by increased Foxp3 expression following
TCR stimulation in human and mouse cells (Chen et al., 2003;
Fantini et al., 2004; Wan and Flavell, 2005). These studies
prompted later investigation on TGF-b function in nTreg develop-
ment and revealed that TGF-b is required for both the develop-
ment and the peripheral maintenance of nTreg cells in mice
(Marie et al., 2005; Liu et al., 2008). TGF-b1 is obligatory for
the generation of both Treg and Th17 cells, with additional cyto-
kines such as IL-6 or IL-21 for the latter. In addition, it is also
involved in the differentiation of newly identified Th9 cells
(Dardalhon et al., 2008; Veldhoen et al., 2008). The mechanism
through which TGF-b achieves such diverse functions needs to
be addressed in the future.
IL-10. IL-10 is a cytokine first described as cytokine synthesis
inhibitory factor (Fiorentino et al., 1989). The binding of IL-10
to its receptor activates JAK1/Tyk2-STAT1a and 3 in target T
cells. IL-10 is a cytokine highly expressed in Tr1 cells and is
critical for the function of this Treg subset. IL-10 promotes
the generation of Tr1 cells in vitro. When human or mouse
CD4þ T cells are chronically activated in the presence of
IL-10, they differentiate into Tr1 cells (Groux et al., 1997;
Bacchetta et al., 2002). However, whether IL-10 signaling is
crucial for the generation or function of Tr1 cell in vivo
remains to be tested.
MAP kinase pathways
Following TCR and cytokine receptor activation, the MAPK signal-
ing cascade is engaged. Three key components of MAPK path-
ways; ERK, JNK and p38 are constitutively expressed in T cells.
Their activation relies on being phosphorylated by upstream
kinases. JNK and p38 MAPK are both reportedly involved in Th1
and Th2 differentiation. JNK1-deficient CD4 T cells preferentially
expressed IL-4 without a defect in IFN-g production (Constant
et al., 2000; Dong et al., 2000). JNK2, however, is selectively acti-
vated in Th1 cells following TCR stimulation and required for IFN-g
production (Yang et al., 1998). p38 MAPK was shown to preferen-
tially participate in IFN-g production, because inhibition of p38 by
a pharmacological drug SB203580 or a dominant negative form of
p38 resulted in diminished IFN-g expression with no effect on IL-4
secretion. In addition, a constitutively active form of MKK6, an
MAPK that activates p38 MAPK, augmented IFN-g production
(Rincon et al., 1998). GADD45g, a factor able to activate p38
and JNK independent of MAPK, is rapidly and preferentially
induced in Th1 cells (Lu et al., 2001). CD4 T cells lacking
GADD45g displayed reduced IFN-g and Th1 responses, correlating
with diminished p38 MAPK and JNK activity (Lu et al., 2001).
MAPKs play an important role of relaying upstream cell surface
signal to the downstream nuclear factors. Because of the vast
numbers of family members and extensive crosstalk among
them, pinpointing the specific function of each MAPK in Th differ-
entiation is difficult. Nevertheless, the importance of MAPK in
these biological processes has been demonstrated and further
investigation is warranted. Because many pharmacological
drugs targeting MAPKs have been and are being developed, infor-
mation gained from studying MAPK in T cell differentiation may
readily be translated into clinical benefits of treating immune dis-
eases in humans.
Transcription factors
Cytokine expression profile defines and determines effector T cell
lineages. As always seen in developmental biology where a
specific lineage correlates with the activity of one or more tran-
scription factors, studies were set forth to investigate whether
different Th lineages are controlled by specific transcription
factors. Great progress has been made in the endeavor; the tran-
scription factors controlling Th1, Th2, Th17 and Treg differen-
tiation have been identified.
For Th1 differentiation
T-bet
T-bet, also known as Tbx21 (Szabo et al., 2000), belongs to the
T-box family of transcription factors and is the only known T-box
gene specifically expressed in the lymphoid system. T-bet is
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rapidly and specifically induced in developing Th1 but not Th2 cells,
and its expression appears to be controlled by both TCR and
IFN-gR-STAT1 signals (Lighvani et al., 2001; Afkarian et al., 2002),
but not by the IL-12-STAT4 pathway (Lighvani et al., 2001; Mullen
et al., 2001; Afkarian et al., 2002). T-bet expression seems to be
self-regulated; retrovirally expressed T-bet induced T-bet in Th2
cells (Mullen et al., 2002), which is dependent on STAT1 (Afkarian
et al., 2002), likely through IFN-g signaling. Indeed, IFN-gR-STAT1
signaling maintains high-level of T-bet expression in developing
Th1 cells (Lighvani et al., 2001; Afkarian et al., 2002). Thus, in a
feed-forward manner, IFN-g promotes Th1 commitment through
T-bet (Mullen et al., 2001; Afkarian et al., 2002).
Gain- and loss-of-function studies of T-bet highlight T-bet’s role in
Th1 development. In vitro, retrovirus-mediated over-expression of
T-bet in differentiating or fully differentiated Th2 cells resulted in
an induction of IFN-g expression, accompanied by a reduction of
IL-5 and, to a lesser extent, of IL-4 (Szabo et al., 2000). Such an
effect of T-bet is cell-intrinsic because IL-4 and IL-5 expression
were unchanged in control Th2 cells that co-existed in the same
culture. Under similar experimental settings, the strength of TCR
signaling appeared to be important in quantitatively affecting
T-bet expression levels and thus Th1 differentiation (Afkarian
et al., 2002). In addition, T-bet-deficient CD4 T cells failed to
produce IFN-g in response to TCR stimulation, even under
Th1-polarizing conditions. These mice failed to mount a Th1
response to either protein antigen immunization or to L. major
infection; instead an increase of Th2 cytokines was observed
(Szabo et al., 2002) contributing to the spontaneous asthmatic con-
dition found in these mice (Finotto et al., 2002). Therefore, T-bet is
critically involved in initiating Th1 development through both indu-
cing the Th1 program and repressing the opposing Th2 program.
Hlx
Hlx is a Th1-specific homeobox gene that interacts specifically
with T-bet. Its expression becomes detectable 3 days after Th1
differentiation and is restricted to Th1 but not Th2 T cell clones
(Mullen et al., 2002). Hlx appears to be a target gene for T-bet
because retrovirus-mediated expression of T-bet and a dominant
negative form of T-bet induced and inhibited Hlx expression,
respectively. Hlx and T-bet synergistically promote IFN-g
expression when co-expressed (Mullen et al., 2002). Thus, as a
cofactor for T-bet, Hlx appears to enhance the activities of T-bet
and thus Th1 differentiation. Further study is needed to investi-
gate whether Hlx promotes or is required for optimal Th1
responses under physiological conditions.
STAT4
STAT4 is critical for IL-12 signaling and thus the full commitment of
Th1 cells (Ouyang et al., 1999; Yang et al., 1999). However, it is dis-
pensable for initial IFN-g expression (Magram et al., 1996b; Kaplan
et al., 1998; Schijns et al., 1998; Brombacher et al., 1999; Oxenius
et al., 1999; Mullen et al., 2001; Jankovic et al., 2002). The mechan-
ism of STAT4-promoted IFN-g expression is largely unknown. STAT4
may act through binding to regulatory genomic regions of the IFN-g
gene (Xu et al., 1996) or through interacting with general transcrip-
tional co-activators p300/CBP (Bhattacharya et al., 1996; Zhang
et al., 1996; Korzus et al., 1998). Thus, with need-to-be-defined
mechanisms, STAT4 is critical for amplifying IFN-g production, but
not the initial IFN-g expression.
For Th2 differentiation
GATA-3
GATA-3 is a member of the GATA family of transcription factors.
While it was previously shown to be critical for embryo develop-
ment, GATA-3 dictates Th2 differentiation by regulating Th2 cyto-
kine production (Zheng and Flavell, 1997) through binding to the
IL-4 locus that encompasses the IL-4, IL-5 and IL-13 genes. Forced
expression of GATA-3 in Th1 cells led to the induction of IL-4 pro-
duction (Zheng and Flavell, 1997). Th2 differentiation and
responses are virtually abolished in vitro and in vivo when
GATA-3 is deficient in T cells (Zheng and Flavell, 1997). In
addition, even in fully differentiated Th2 cells, abrogation of
GATA-3 blocked IL-5 and IL-13 production (Zhu et al., 2004),
although IL-4 production was only modestly affected, likely due
to the fact that GATA-3-binding sites were found in the promoters
of IL-5 and IL-13 but not in IL-4.
STAT6
STAT6, activated by IL-4 stimulation, is the major signal transdu-
cer in IL-4-mediated Th2 differentiation in vitro (Shimoda et al.,
1996; Takeda et al., 1996; Kaplan et al., 1996a). However, in
vivo, Th2 responses can be obtained independently of STAT6
(Finkelman et al., 2000; Jankovic et al., 2000; Min et al., 2004).
In vitro, one of the mechanisms of STAT6 is to promote Th2 differ-
entiation through inducing high levels of the transcription factor
GATA-3. STAT6 activities were found necessary and sufficient for
inducing GATA-3 (Kurata et al., 1999; Zhu et al., 2001).
c-Maf, IRF-4 and Gfi-1
c-Maf is an AP-1 family transcription factor selectively
up-regulated in Th2 cells. It is required for the production of
IL-4 but not other Th2 cytokines (Kim et al., 1999). IRF-4 is also
shown to be required for Th2 cell differentiation (Lohoff et al.,
2002; Rengarajan et al., 2002). IRF-4-deficient cells produce
much less IL-4, but this defect can be rescued by over-expression
of GATA-3, suggesting that IRF-4 promotes Th2 differentiation
through up-regulating GATA-3 (Lohoff et al., 2002). Gfi-1 is a tran-
scription factor immediately induced following IL-4-stimulation
(Zhu et al., 2004) and TCR stimulation. Gfi-1 appears to function
by selecting GATA-3hi cells for growth by modulating both
upstream and downstream events of IL-2 signaling (Zhu et al.,
2004, 2006).
For Th17 differentiation
Retinoic acid-related orphan receptors (ROR) are the key tran-
scription factors in Th17 differentiation. ROR-gt mRNA is upregu-
lated in T cells in response to IL-23 and its expression highly
correlates with IL-17 expression (Ivanov et al., 2006). Forced
expression of ROR-gt in naı̈ve CD4þ T cells induced Th17. IL-17
expression was greatly reduced if the CD4 T cells were deficient
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in ROR-gt. In vivo, ROR-gt deficiency led to drastically reduced
Th17 cells, although residual IL-17-producing cells were found.
Therefore, ROR-gt appears to be necessary for Th17 differen-
tiation. The target genes directly regulated by ROR-gt have not
yet been identified, although IL-17 is a good candidate because
conserved ROR responsive elements were found in its promoter
(Jetten et al., 2001). ROR-gt deficiency did not result in total abro-
gation of Th17 differentiation. This could be owing to partial com-
pensation from another ROR family member, ROR-a. ROR-a is
highly expressed in Th17 cells and can be induced by TGF-b
and IL-6. Through ectopic expression, ROR-a promoted Th17
differentiation by itself or synergistically with ROR-gt. ROR-a
deficiency led to Th17 reduction (Yang et al., 2008). Therefore,
ROR-a and ROR-gt are both critical and somewhat redundant in
promoting Th17 differentiation. Further studies are needed to
investigate the mechanisms through which ROR controls Th17
differentiation and the roles of other factors, besides ROR, in reg-
ulating Th17 differentiation.
For Treg differentiation
Foxp3 is an X-linked transcription factor belonging to the
Fork-head protein family. It is specifically highly expressed in
nTreg cells and can be induced by TGF-b following antigenic
stimulation in iTreg cells. Since its discovery in 2002, Foxp3 is
now recognized as the master regulator for functional Treg.
Over-expression of Foxp3 in conventional T cells converts them
to a Treg phenotype endowed with anergy and suppressive
activity (Fontenot et al., 2003). Mutation of Foxp3 in human and
mice invariably results in systemic lymphoproliferative auto-
immune syndrome in Immunodeficiency, Polyendocrinopathy,
and Enteropathy, X-Linked Syndrome patients and Scurfy mice
because of the lack of functional Treg (Chen et al., 2003).
Continuous expression of Foxp3 is critical for maintaining the sup-
pressive activity of Treg cells (Williams and Rudensky, 2007), and
reduced Foxp3 expression led to abrogated suppressive function
and a conversion of Treg cells into Th2 like cells (Wan and Flavell,
2007). Substantial efforts have been invested to elucidate how
Foxp3 functions in Treg. It appears that Foxp3 is able to affect
hundreds of target genes but the ones specific for Treg function
have been elusive. In addition, Foxp3-expressing cells were
shown to be generated even in the absence of Foxp3 protein
(Gavin et al., 2007). Therefore, Foxp3 is not absolutely required
for the development of Treg but rather is critical for the establish-
ment and stabilization of the suppressive function of these cells
(Gavin et al., 2007). Obviously, much work is needed to address
how Foxp3 functions and is regulated in T cells.
Mutual-exclusion, plasticity
and interconvertibility of
effector T cells: when the
boundary blurs
While we appreciate the seemingly clear delineation of different
classes of effector T cells, we start to realize that nature works
its wonders in an efficient and yet not-so-simple way—different
Th cells not only functionally interact but also possess plasticity
and inter-convertibility (Figure 1).
Mutual exclusion
Th1 and Th2 programs were found to be mutually exclusive
since the day they were discovered. Immediately following TCR
activation, IFN-g and IL-4 are both upregulated in a cytokine-
independent manner. Within hours of activation, the cytokine-
dependent phase of Th development ensues. At this stage, the
induction and maintenance of high-levels of T-bet or GATA-3
expression appears necessary for Th1 or Th2 commitment,
respectively (Grogan et al., 2001). T-bet expression is promoted
by the IFN-gR-STAT1 pathway (Lighvani et al., 2001; Afkarian
et al., 2002) and by itself (Mullen et al., 2002). T-bet may potenti-
ate IFN-g production by stably remodeling the chromatin sur-
rounding the IFN-g gene to achieve permanent lineage
commitment. While IFN-g production is maintained, IL-4
expression is extinguished in developing Th1 cells. The IFN-g
and IL-12 signaling pathways have been implicated in the sup-
pression of GATA-3 expression (Ouyang et al., 2000) and in the
silencing of the Th2 loci (Manetti et al., 1993; Seder et al.,
1993; Hsieh et al., 1993b; Mountford et al., 1999). Developing
Th1 cells are further sustained through T-bet-induced expression
of IL-12Rb2 (Mullen et al., 2001; Afkarian et al., 2002), facilitating
their response to the Th1-driving cytokine IL-12. Thus, early T-bet
expression appears to be a master switch to turn on the Th1
program while turning off the Th2 program. In a similar fashion,
the Th2 lineage commitment factor GATA-3 switches on the Th2
program but turns off the Th1 program (Zheng and Flavell,
1997). GATA-3 is predominantly induced by the IL-4-STAT6 signal-
ing pathway (Ouyang et al., 1998; Kurata et al., 1999) to both
increase IL-4 production and suppress IFN-g and IL-12Rb2
expression (Ouyang et al., 1998; Ferber et al., 1999), potentially
through remodeling chromatin to make Th2 loci more accessible
(Lee et al., 2000; Ouyang et al., 2000). Thus, T-bet or GATA-3
decides a common precursor to follow the Th1 or Th2 path.
After a decision is made, the differentiation program of the
other lineage will be shut off. The exact mechanism of how
T-bet and GATA3 reciprocally regulate the expression of Th1
and Th2 cytokines at the epigenetic level is an important ques-
tion. Interestingly, it has been found that the loci encoding
IFN-g and IL-4 are physically close during Th1–Th2 differentiation
and become separated after full differentiation (Spilianakis et al.,
2005). Thus, gene loci on different chromosomes can juxtapose,
allowing a common regulatory complex to be used for Th1–Th2
differentiation.
Soon after the discovery of Th17 cell, the studies of its relation-
ship with other known Th cells ensued. Based mostly on the
studies in vitro, Th17 and iTreg were found to be mutually exclu-
sive (Korn et al., 2007). Following activation in the presence of
TGF-b, CD4 T cells differentiate into Foxp3-expressing iTreg
without IL-17 expression. However, if IL-6 is also present, acti-
vated CD4 T cells deviate to Th-17 cells without Foxp3 expression.
The mechanism of such a mutual exclusion could be owing to
Foxp3 expression in iTreg and ROR-gt expression in Th17 cells.
It appears that high-level Foxp3 expression leads to the
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repression of ROR-gt and thus Th17 differentiation, and ROR-gt
expression inhibits Foxp3 and prompts IL-17 production (Zhou
et al., 2008). What is worth mentioning is that iTreg seem to be
in a particular situation in that the high level of Foxp3 expression
induced by TGF-b results in the shut-down of all known lineage
development. It thus appears that Foxp3 function supersedes
all transcription factors for T cell differentiation. With the increas-
ing interest in Th17 and Treg, more efforts will be invested in
addressing how these two cell fates are determined in relation
with other known effector T cells.
Plasticity and inter-convertibility
We have become accustomed to the idea that different Th cells
are ‘committed’ to their path. Certainly, most in vitro differen-
tiation models suggest this is the case and such ‘commitments’
provide simplified experimental models to allow us understand
Th cell functions and gene regulation. T cells in our body often
have to mount different responses towards different insults on
a short notice. The time required to let recently activated Th
cells die, to replenish the apoptotic T cells and then to launch
another effective immune response might be too long to accom-
modate such a task. One may question: are Th cells really fully
committed? And is it possible that Th cells possess certain plas-
ticity so that they can convert into other types of effectors
under the right conditions? Thus, the body can fight insults
more quickly and more energy-efficiently.
Recently, emerging evidence suggests that under certain con-
ditions, seemingly committed T cells indeed possess plasticity
and may convert into other types of effector cells (Figure 1).
Long-lived Th1 effector/memory cells are able to turn off IFN-g
expression in vivo, appearing to be ready to ‘re-differentiate’
(Harrington et al., 2008). nTreg may downregulate Foxp3
expression and generate Th2 cytokines during autoimmune syn-
drome and lung allergic responses (Wan and Flavell, 2007;
Joetham et al., 2008). In addition, when the Treg lineage CD4 T
cells lose Foxp3 expression, they generate IL-4, IFN-g as well as
IL-17 (Gavin et al., 2007). Moreover, nTreg can become Th17
cells in the presence of activated inflammatory DC, likely
through the action of IL-6 (Radhakrishnan et al., 2008).
Seemingly fully differentiated Th17 cells were also shown to
convert into Th1 cells in the absence of TGF-b (Lee et al.,
2009). How Th cells achieve such plasticity is a question not
fully addressed. One contributing mechanism could be that the
permissive epigenetic states of the entire set of genes associated
with different lineages in a particular Th subset allow its alterna-
tive paths (Wei et al., 2009). Under physiological conditions, how
such plasticity is achieved and what decides the inter-conversion
amongst different Th cells are important questions that need
further investigation.
Closing remarks
We appreciate the functional importance of Th cells in fighting
pathogens, inducing inflammation and autoimmunity as well as
maintaining self-tolerance and immune homeostasis. Th cells
accomplish such tasks by deploying specialized lineages—Th1,
Th2, Th17, Tfh, Th9 and Treg, with certain overlapping functions.
Current knowledge gained on the function and regulation of Th
cells derives mostly from a reductionist approach using well-
controlled, simplified in vitro differentiation systems. With the
development of reporter mice that allow us to track different Th
subsets in vivo, in the future we will be able to address how Th
cells function and are induced under physiological settings.
Recent discovery of several new Th lineages on one hand
further energizes the research on Th cells; on the other hand, it
raises the question of how many ‘Th lineages’ truly exist. More
importantly, as we start to realize that Th cells are plastic and
can be converted into other Th cells, especially under physiologi-
cal conditions, it becomes possible that the traditionally defined
‘Th lineage’ might not be terminally differentiated but rather
transiently specialized effector T cells that are ready to perform
different tasks to efficiently counter various immune insults. In
the future, study will be needed to elucidate the mechanisms
through which T cells acquire and re-acquire particular cytokine
profiles to regulate immunity in an ever-changing micro-
environment. Nevertheless, one consistent theme in Th biology
is that the cytokine milieu dictates what specialized effector T
cells are induced. Much more work is needed in the years to
come to reveal what effects different cytokines and their combi-
nations have on Th function and through what mechanisms.
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